16. Dezember 2025
Fähzan Ahmad • 16. Dezember 2025
How “certified” cosmetic manufacturers still break GMP in daily operations.

ISO 22716 defines Good Manufacturing Practice for cosmetics. Yet most GMP failures do not stem from missing procedures—they stem from procedures that are not operationally enforced.
The dominant misconception is that GMP equals documentation. In reality, GMP is process behavior under deviation. Auditors focus on how production reacts when something goes wrong: raw material delays, batch adjustments, rework, staff substitution. If the system collapses under deviation, GMP is not implemented—regardless of certificates.
Common failure points include informal batch corrections, undocumented parameter changes, and operator-dependent decisions. These actions often leave no trace in batch records yet directly affect product consistency. Regulators classify this as loss of process control, not clerical error.
True GMP implementation requires decision traceability. Every non-standard action must be predefined, logged, and justified. Without this, manufacturers rely on tacit knowledge—acceptable in R&D, unacceptable in production.
At Makrolife Biotech, GMP audits focus on behavioral compliance: how teams act when SOPs are insufficient. This is where most cosmetic GMP systems fail—and where regulatory exposure begins.
GMP is not what you wrote down.
It is what happens when reality diverges from the plan.








